These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29419393)

  • 1. A keen eye for risk.
    Ford TJ; Rocchiccioli P
    BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial hypercholesterolaemia: A guide for general practice.
    Brett T; Arnold-Reed D
    Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827
    [No Abstract]   [Full Text] [Related]  

  • 3. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia.
    Ortega Martínez de Victoria E
    Endocrinol Diabetes Nutr; 2017; 64(7):341-344. PubMed ID: 28745604
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hypercholesterolemia: Detect, treat, and ask about family.
    Shah NP; Ahmed HM; Wilson Tang WH
    Cleve Clin J Med; 2020 Feb; 87(2):109-120. PubMed ID: 32015064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies in addition to statin therapy lowers LDL cholesterol].
    Bossenmayer S
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1728. PubMed ID: 23281534
    [No Abstract]   [Full Text] [Related]  

  • 6. Corneal arcus and xanthomas in homozygous familial hypercholesterolemia: first report from China.
    Meng X; Lin J; Gao X; Guo J; Xin C; Wang J
    Indian J Ophthalmol; 2013 Dec; 61(12):770-1. PubMed ID: 24088637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Winner by points?--LDL cholesterol as a target for therapeutic intervention.
    Tietge UJ
    Curr Opin Lipidol; 2013 Jun; 24(3):277-8. PubMed ID: 23652473
    [No Abstract]   [Full Text] [Related]  

  • 8. A Small Change Can Make a Big Difference: A Lesson from Evolocumab.
    Mirzaee S; Thein PM; Wong D; Nasis A
    Heart Lung Circ; 2019 Mar; 28(3):e21-e22. PubMed ID: 29685715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy and clinical trials.
    Sodhi N; Krasuski RA
    Curr Opin Lipidol; 2013 Jun; 24(3):281-2. PubMed ID: 23652475
    [No Abstract]   [Full Text] [Related]  

  • 10. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
    Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
    Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypercholesterolemia. What the zebra can teach us about the horse.
    Hoeg JM
    JAMA; 1994 Feb; 271(7):543-6. PubMed ID: 8301770
    [No Abstract]   [Full Text] [Related]  

  • 12. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
    Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
    Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CardioPulse: The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors.
    Blind E; de Graeff PA; Meurs I; Holtkamp F; Baczynska A; Janssen H
    Eur Heart J; 2016 Feb; 37(6):502-3. PubMed ID: 26853264
    [No Abstract]   [Full Text] [Related]  

  • 14. [PCSK9 inhibitors: new treatment to lower cholesterol].
    Gencer B; Rodondi N; Mach F
    Rev Med Suisse; 2016 Mar; 12(508):440-2, 444. PubMed ID: 27089600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue therapy with PCSK9 inhibitors for patients with delayed diagnosis of heterozygous familial hypercholesterolemia: Redressing the balance of missed opportunities.
    Vuorio A; Watts GF; Kovanen PT
    J Clin Lipidol; 2016; 10(5):1278-9. PubMed ID: 27678448
    [No Abstract]   [Full Text] [Related]  

  • 16. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In brief: Repatha Pushtronex--a new evolocumab injection device.
    Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effective LDL cholesterol reduction for high risk patients].
    Einecke D
    MMW Fortschr Med; 2016 Apr; 158(8):84. PubMed ID: 27116175
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of proprotein convertase subtilisin/kexin type 9 in the treatment of hypercholesterolemia.
    Ascaso JF
    Endocrinol Nutr; 2016; 63(6):255-7. PubMed ID: 27050861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.